Inventor

Roy C. Levitt

Inventor
Ambler, PA, US

Overview

26→
Patents
1995–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 26 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations27%
A61KPreparations for medical, dental or toiletry purposes26%
C07KPeptides20%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms6%
G01NInvestigating or analysing materials by determining their chemical or physical properties5%
C07JSteroids3%
C12NMicroorganisms or enzymes3%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests3%
A61MDevices for introducing media into, or onto, the body1%
C07CAcyclic or carbocyclic compounds1%
PatentTitleYear
11,091,763Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors202110,550,389Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors20208,940,683'Localized therapy of lower airways inflammatory disorders with proinflammatory cytokine inhibitors'20158,716,270'Polymorphic and amorphous salt forms of squalamine dilactate'20148,637,469'Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors'20147,981,876'Polymorphic and amorphous salt forms of squalamine dilactate'20117,919,248'Methods for the modulation of IL-13'20117,704,710'Interleukin-9 receptor mutants'20107,700,088'Interleukin-9 mutein peptides'20107,504,409'Mucin synthesis inhibitors'20097,384,767'Nucleic acid encoding an interleukin-9 receptor variant'20087,345,051'Mucin synthesis inhibitors'20087,211,254'Methods for treating ICACC protein associated diseases'20077,208,292'Nucleic acid encoding an interleukin-9 receptor variant'20077,192,578'Interleukin-9 mutein peptides'20077,074,778'Asthma associated factors as targets for treating atopic allergies including asthma and related disorders'20067,056,698'Nucleic acids encoding interleukin-9 receptor variants'20066,737,427'Mucin synthesis inhibitors'20046,716,603'Nucleic acids encoding a chloride channel protein'20046,645,492'Methods of treating asthma with interleukin-9 receptor antibodies'20036,602,850'Method of treating asthma using soluble IL-9 receptor variants'20036,576,434'Methods for identification of agents which modulate chloride channel activity'20036,261,559'Methods of treating asthma with interleukin-9 antibodies'20016,037,149'DNA encoding human asthma associated factor 1'20005,908,839'Asthma associated factors as targets for treating atopic allergies including asthma and related disorders'19995,384,462'Process and apparatus for localizing a source of charged particles using an electric field'1995

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1995Based in Towson, MD, US· patent location history
1999–2000Patents assigned to MAGAININ PHARMA (2)· patent assignee history
1999–2010Based in Ambler, PA, US· patent location history
2001–2010Patents assigned to GENAERA CORP (16)· patent assignee history
2003–2011Based in Plymouth Meeting, PA, US· patent location history
2014–2020Patents assigned to LEVITT ROY C (3)· patent assignee history
2014Patents assigned to ARMBRUSTER KYLE (1)· patent assignee history
2014–2021Based in Miami, FL, US· patent location history
2014–2015Based in Coconut Grove, FL, US· patent location history
2021Patents assigned to ALTAVANT SCIENCES GMBH (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GENAERA CORP162001–2010
LEVITT ROY Cself32014–2020
MAGAININ PHARMA21999–2000
ALTAVANT SCIENCES GMBH12021
ARMBRUSTER KYLE12014
Locations
LocationPatentsSpan
Ambler, Pennsylvania, US131999–2010
Plymouth Meeting, Pennsylvania, US72003–2011
Miami, Florida, US32014–2021
Coconut Grove, Florida, US22014–2015
Towson, Maryland, US11995